Be Familiar With Saphnelo for Lupus

October 2022

Saphnelo (anifrolumab) will be the second biologic for adults with systemic lupus erythematosus (SLE)...after Benlysta (belimumab).

This autoimmune disease can affect almost any organ in the body...and cause pain, rashes, fever, etc.

Saphnelo and Benlysta are monoclonal antibodies that suppress the immune system in different ways. Saphnelo inhibits type I interferons...Benlysta inhibits B cells.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Influenza Know What’s Changed With Flu Immunizations for 2022-2023
COVID-19 Be Ready With Answers About Bivalent COVID-19 Boosters
NSAIDs Consider Kidney Risks Before Suggesting an NSAID
Adverse Events Put Torsades Risk With Cholinesterase Inhibitors in Perspective
Allergic Reactions Sort Through Specifics of Sulfa Allergies
Gastroenterology Follow a Stepwise Approach to Managing Gastroparesis
Heart Failure Help Patients Avoid Meds That Can Exacerbate Heart Failure
Lupus Be Familiar With Saphnelo for Lupus
Hypotension Save Meds as a Last Resort for Orthostatic Hypotension

Be Familiar With Saphnelo for Lupus

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents